// App-Quantinova.ai

Abstract 31 : The ATTICUS Randomized Controlled Trial - Subgroup Analyses

Researchers

Presenter

  • Sven Poli

Principal Investigators

  • Timea Keller

  • Peter Martus

  • Khouloud Poli

  • Ulf Ziemann

  • Tobias Geisler

Medical Centers

  • UNIVERSITY HOSPITAL TUEBINGEN, Tuebingen, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Central Nervous System (CNS)

Disease

  • Atrial septal defect

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Albyl-E

  • apixaban

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Open Label

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • NCT02427126

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved